NO952987L - Sårhelende blanding - Google Patents

Sårhelende blanding

Info

Publication number
NO952987L
NO952987L NO952987A NO952987A NO952987L NO 952987 L NO952987 L NO 952987L NO 952987 A NO952987 A NO 952987A NO 952987 A NO952987 A NO 952987A NO 952987 L NO952987 L NO 952987L
Authority
NO
Norway
Prior art keywords
wound healing
healing mixture
growth factor
insulin
mixture
Prior art date
Application number
NO952987A
Other languages
English (en)
Norwegian (no)
Other versions
NO952987D0 (no
Inventor
George N Cox
Thomas A Mustoe
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of NO952987D0 publication Critical patent/NO952987D0/no
Publication of NO952987L publication Critical patent/NO952987L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO952987A 1993-01-29 1995-07-27 Sårhelende blanding NO952987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1103193A 1993-01-29 1993-01-29
PCT/US1994/000799 WO1994016723A2 (fr) 1993-01-29 1994-01-25 Composition de cicatrisation de plaies

Publications (2)

Publication Number Publication Date
NO952987D0 NO952987D0 (no) 1995-07-27
NO952987L true NO952987L (no) 1995-08-30

Family

ID=21748560

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952987A NO952987L (no) 1993-01-29 1995-07-27 Sårhelende blanding

Country Status (8)

Country Link
EP (1) EP0686040A1 (fr)
JP (1) JPH09500088A (fr)
KR (1) KR960700069A (fr)
AU (1) AU6093794A (fr)
CA (1) CA2154078A1 (fr)
FI (1) FI953615A (fr)
NO (1) NO952987L (fr)
WO (1) WO1994016723A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM678294A0 (en) * 1994-07-13 1994-08-04 Gropep Pty Ltd Use of insulin-like growth factor in combination with insulin
ATE274056T1 (de) * 1995-10-11 2004-09-15 Chiron Corp Kombination pdgf, kgf, igf und igfbp zur wundheilung
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
JP3971108B2 (ja) 1999-01-06 2007-09-05 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ突然変異体
AUPQ585500A0 (en) * 2000-02-25 2000-03-16 Gropep Pty Ltd Treatment for peripheral sensory neuropathy
WO2001087323A2 (fr) 2000-05-16 2001-11-22 Genentech, Inc. Procede de traitement des lesions du cartilage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3178714B2 (ja) * 1988-07-15 2001-06-25 セントラル・シドニー・エリア・ヘルス・サービス インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ）
CA2090702A1 (fr) * 1990-08-28 1992-03-01 Michael C. Kiefer Proteine igfbp-5 possedant une forte affinite pour un facteur de croissance de substances apparentees a l'insuline
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
ES2174852T3 (es) * 1992-08-26 2002-11-16 Celtrix Pharma Metodo para el tratamiento sistemico de estados catabolicos y lesiones sistemicas de tejidos.

Also Published As

Publication number Publication date
JPH09500088A (ja) 1997-01-07
WO1994016723A2 (fr) 1994-08-04
EP0686040A1 (fr) 1995-12-13
CA2154078A1 (fr) 1994-08-04
FI953615A0 (fi) 1995-07-28
NO952987D0 (no) 1995-07-27
WO1994016723A3 (fr) 1994-09-15
KR960700069A (ko) 1996-01-19
FI953615A (fi) 1995-07-28
AU6093794A (en) 1994-08-15

Similar Documents

Publication Publication Date Title
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
AU5431390A (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
ATE255589T1 (de) Kristallin form i von clarithromycin
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
NO962286L (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
SE9504661D0 (sv) New compounds
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
AU2740797A (en) Androstene derivatives
CY1108110T1 (el) Παραγοντες και μεθοδοι για προστασια, θεραπεια και επιδιορθωση συνδετικου ιστου
FI971536A0 (fi) Keratinosyytti-kasvutekijän analogeja
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
DK0888323T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
ES2139081T3 (es) Composiciones farmaceuticas que contienen la hormona humana del crecimiento.
NO952987L (no) Sårhelende blanding
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
NO962285D0 (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
AR020832A1 (es) Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5-(10)-en-20-in-3-ona
CA2201944A1 (fr) Analogues du facteur de croissance des keratinocytes ayant une stabilite de temperature amelioree
ATE66610T1 (de) Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako- kosmetische kompositionen.
SE9504662D0 (sv) New compounds
DK1074264T3 (da) Inhibitorer for neovaskularisering
DE69431662D1 (de) Stabilisierte tablettenformulierung
DK0695303T3 (da) Hidtil ukendte pyridiniumsalte og deres anvendelse til bekæmpelse af Helicobacter-bakterier